Admit Therapeutics S.L.
Latest round
- Seed
Last raised
- Mar 2019
Total raised
- $0.2M
Investors
- 3
About Admit Therapeutics S.L.
L. is a spin off from the Bellvitge Biomedical Research Institute that develops diagnostic technology based on an epigenetic analysis of blood samples that covers the analysis of many methylcytosines in mtDNA by next-generation sequencing. Marta Barrachina (CEO), Jordi Gascón, and Ramon Reñé are the co-founders of the company.L., the Alzheimer's Drug Discovery Foundation, WA4Steam, the European Innovation Council, and the Ship2B Foundation. The company’s primary product is a diagnostic test designed to identify Alzheimer’s disease at its earliest stages. This test utilizes epigenetic analysis of blood samples, where it examines many methylcytosines in mitochondrial DNA (mtDNA) through next-generation sequencing. This approach is based on the premise that systemic mitochondrial dysfunction occurs before the formation of cerebral abnormal protein aggregates. Admit Therapeutics focuses on epigenetic markers, offering several advantages such as early detection, non-invasiveness, and analysis. Some of the company’s partners include Eit Health, Bellvitge, KnightADRC, Cita Alzheimer, Aibl, and others.
Who invested in Admit Therapeutics S.L.
3 investors across 1 round
See all investors in Admit Therapeutics S.L.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 19, 2019
Amount
$0.2M
Investors
Questions about Admit Therapeutics S.L.
Who invested in Admit Therapeutics S.L.?
Admit Therapeutics S.L. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Admit Therapeutics S.L. raised?
Admit Therapeutics S.L. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Admit Therapeutics S.L. last raise money?
Admit Therapeutics S.L.'s most recent round on record is a Seed, in Mar 2019.
What does Admit Therapeutics S.L. do?
Admit Therapeutics S.L. is a biotechnology company.
Where is Admit Therapeutics S.L. headquartered?
Admit Therapeutics S.L. is headquartered in Barcelona, Spain.
Which VCs invest in companies like Admit Therapeutics S.L.?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Admit Therapeutics S.L.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Admit Therapeutics S.L.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.